Back to 
Sculptor Capital LP
Sculptor Capital LP
QNCX
3 quarters
Position history for Sculptor Capital LP's holdings in QUINCE THERAPEUTICS INC
No. Sculptor Capital Management exited its QNCX (Quince Therapeutics) position in Q2 2022. Its Q1 2022 13F listed 223,800 shares worth $1.4M. Sculptor Capital Management first reported QNCX in Q4 2021 and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$2.8M
Total Shares Change
-223,800
Quarter-by-Quarter History
Other major holders of QNCX: Capital World Investors, Capital International Investors, Capital Research Global Investors